Royce & Associates’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-102,900
| Closed | -$916K | – | 912 |
|
|
2024
Q2 | $916K | Hold |
102,900
| – | – | 0.01% | 727 |
|
|
2024
Q1 | $1.04M | Hold |
102,900
| – | – | 0.01% | 720 |
|
|
2023
Q4 | $1.04M | Hold |
102,900
| – | – | 0.01% | 735 |
|
|
2023
Q3 | $964K | Sell |
102,900
-4,923
| -5% | -$46.1K | 0.01% | 744 |
|
|
2023
Q2 | $2.64M | Buy |
107,823
+56,516
| +110% | +$1.39M | 0.03% | 628 |
|
|
2023
Q1 | $1.19M | Sell |
51,307
-5,596
| -10% | -$130K | 0.01% | 740 |
|
|
2022
Q4 | $1.44M | Buy |
56,903
+28,595
| +101% | +$724K | 0.02% | 697 |
|
|
2022
Q3 | $546K | Buy |
+28,308
| New | +$546K | 0.01% | 807 |
|